Vera Therapeutics, Inc. (VERA) insider trading.
In Q3 2026, insiders at Vera Therapeutics, Inc. reported 21 non-derivative transactions on 9 Forms 3, 4 and 5: 0 open-market purchases and 14 sales worth $6.6M.
- Transactions
- 21
- Purchases (P)
- 0
- Sales (S)
- 14
- Net shares, P minus S
- -166,500
- Insiders
- 3
- Last filed
- 2026-09-17
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Fordyce Marshall | Director, Officer · PRESIDENT AND CEO | 19 | 0 | 14 |
| Young Joseph R | Officer · SVP, FINANCE, CHIEF ACCT OFFCR | 1 | 0 | 0 |
| Boman Nancy Lee | Officer · Chief Regulatory Officer | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Fordyce Marshall | S (D) | 18,500 | $37 | 235,244 | Form 4 |
| 2026-09-15 | Fordyce Marshall | M (A) | 18,500 | $2.9 | 253,744 | Form 4 |
| 2026-09-11 | Young Joseph R | M (A) | 5,000 | $3.94 | 80,754 | Form 4 |
| 2026-09-02 | Fordyce Marshall | M (A) | 18,500 | $2.9 | 253,744 | Form 4 |
| 2026-09-02 | Fordyce Marshall | S (D) | 18,500 | $35.12 | 235,244 | Form 4 |
| 2026-08-03 | Boman Nancy Lee | A (A) | 44,987 | $0 | 44,987 | Form 4 |
| 2026-07-07 | Fordyce Marshall | M (A) | 46,250 | $2.9 | 281,494 | Form 4/A |
| 2026-07-07 | Fordyce Marshall | S (D) | 1,000 | $40.78 | 280,494 | Form 4/A |
| 2026-07-07 | Fordyce Marshall | S (D) | 2,200 | $43.59 | 235,244 | Form 4/A |
| 2026-07-07 | Fordyce Marshall | S (D) | 10,500 | $42.86 | 237,444 | Form 4/A |
| 2026-07-07 | Fordyce Marshall | S (D) | 32,550 | $42.07 | 247,944 | Form 4/A |
| 2026-07-07 | Fordyce Marshall | S (D) | 2,200 | $43.59 | 151,994 | Form 4 |
| 2026-07-07 | Fordyce Marshall | S (D) | 32,550 | $42.07 | 164,694 | Form 4 |
| 2026-07-07 | Fordyce Marshall | S (D) | 1,000 | $40.78 | 197,244 | Form 4 |
| 2026-07-07 | Fordyce Marshall | S (D) | 10,500 | $42.86 | 154,194 | Form 4 |
| 2026-06-23 | Fordyce Marshall | M (A) | 18,500 | $2.9 | 253,744 | Form 4/A |
| 2026-06-23 | Fordyce Marshall | S (D) | 88 | $38.43 | 235,244 | Form 4/A |
| 2026-06-23 | Fordyce Marshall | S (D) | 18,412 | $37.93 | 235,332 | Form 4/A |
| 2026-05-12 | Fordyce Marshall | M (A) | 18,500 | $2.9 | 253,744 | Form 4/A |
| 2026-05-12 | Fordyce Marshall | S (D) | 4,281 | $37.09 | 235,244 | Form 4/A |
| 2026-05-12 | Fordyce Marshall | S (D) | 14,219 | $36.64 | 239,525 | Form 4/A |
Transaction codes in this quarter
Get VERA insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1831828&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · VERA company page · Vera Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Vera Therapeutics, Inc. (VERA)?
In Q3 2026, insiders at Vera Therapeutics, Inc. reported 21 non-derivative transactions on 9 Forms 3, 4 and 5: 0 open-market purchases and 14 sales worth $6.6M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Vera Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/vera.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.